Concepedia

Alessandra Banzato

AB

Statistics

Publications

16

Citations

2K

H-Index

16

Active since

2006

Affiliations

University of Padua(Current)

Istituto Oncologico Veneto

University of Brescia

Fidia Farmaceutici (Italy)

Hospital Universitario 12 De Octubre

Alessandra Banzato is an author at University of Padua specializing in medicine, pharmacology, and drug delivery.

Publications per year

2006–2019

16

Publications

16

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Vittorio Pengo, Gentian Denas, Giacomo Zoppellaro et al. · Blood · 2018 · 798 citations · Full text

, , +15

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study

Vittorio Pengo, Amelia Ruffatti, Cristina Legnani et al. · Blood · 2011 · 459 citations · Full text

, , +15

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort

Massimo Radin, Savino Sciascia, Doruk Erkan et al. · Seminars in Arthritis and Rheumatism · 2019 · 114 citations · Full text

, , +14

HYTAD1-p20: A new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer

Antonio Rosato, Alessandra Banzato, Gilda De Luca et al. · Urologic Oncology Seminars and Original Investigations · 2006 · 98 citations

, , +12

A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent <i>In vivo</i> Therapeutic Activity

Alessandra Banzato, Sara Bobisse, Maria Rondina et al. · Clinical Cancer Research · 2008 · 90 citations · Full text

, , +17

1–5 of 16